Johnson Controls and Phylagen sign Healthy Buildings Joint Development Agreement

Johnson Controls (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, today announced it has signed a joint development agreement with Phylagen, a leading biotechnology company in the field of microbiome optimization of indoor environments. Through this agreement, which includes a strategic investment in Phylagen, the companies are developing cutting-edge technology that leverages the science of building microbiomes to advance the future of healthy buildings.